Which appeals can you support?
Which appeals can you support?
Funds donated to the Beatson Pebble Appeal can be directed to any of the following areas;
The Beatson Pebble Appeal
Thanks to the generosity of Beatson Pebble Appeal supporters, and following a successful £10 million fundraising campaign, the Wolfson Wohl Cancer Research Centre was officially opened on 1 May 2014. This cutting-edge research Centre supports existing research and care facilities throughout Glasgow and helps to translate basic science into life-changing treatments for cancer patients.
Scientists at the Wolfson Wohl Centre are currently working on ground-breaking research projects that will transform the way patients with cancer are treated. Glasgow is leading the way in developing new precision medicine techniques which aim to treat patients earlier and more effectively. Continued charitable donations will help us to recruit and retain world-leading scientists and fund vital pieces of equipment and technology.
Prostate Cancer Research
Professor Hing Leung, Professor of Urology and Medical Oncology, of the Wolfson Wohl Cancer Research Centre is at the forefront of prostate cancer research at the University of Glasgow. Donations to this fund have supported clinical trials in Glasgow by helping to speed up the process of collecting and validating data, allowing scientists to produce research results for new treatments sooner. This means that positive results can be introduced into the Clinic and will improve outcomes for patients with prostate cancer.
"Seeing is believing: We have witnessed major advances in biomedical research in recent years and I believe that significant improvement to patient care and outcome can be developed. Talents, commitment and cutting edge technologies in the West of Scotland will be enriched now that the translational research centre is built." Professor Hing Lueng
Think Pink Scotland -Breast cancer
Think Pink Scotland was founded in 2006 by five Scottish women, two of whom were diagnosed with breast cancer in the same week. These remarkable ladies galvanised community support from across the West of Scotland to raise over £380,000 for breast cancer research in the west of Scotland and funded a laboratory in the University of Glasgow’s Wolfson Wohl Cancer Research Centre. Think Pink Scotland continue to fundraise to meet vital funding gaps for scientists, equipment and research.
Currently about one fifth of breast cancers have too much of a protein called HER2 and patients with this type of cancer can be treated with anti-HER2 drugs like Herceptin. However, Herceptin is not effective in every patient and so we are using advanced technology in the Think Pink laboratory to investigate why some cancers are resistant. By understanding this we hope to develop ways of overcoming resistance so that drugs like Herceptin can be used more effectively for more people.
'I have survived cancer three times. The second time my friend and I were both diagnosed with breast cancer in the same week. We decided to make a difference through fundraising for Think Pink Scotland and organised parties, dinners, Christmas concerts and bake sales. We raised £380,000 for breast cancer research funding a laboratory at the research centre at Garscube.'
'My best fundraising tip is to realise every penny counts. Lots of people are keen to donate small amounts of money, or their time, or donate a raffle prize. So small events are just as important as larger ones and they all go to help fund research into cancer treatment.' Lynn Murray- Think Pink Fundraiser
Professor Andrew Biankin, Director of WWCRC, and a world-leader in pancreatic cancer research, moved to Glasgow in 2013 with a vision to revolutionise ways to treat pancreatic cancer. He and the team have recently received substantial funding to lead the PRECISION-Panc project, which will focus on matching patients to treatments most likely to work for their type of pancreatic cancer.
Because pancreatic cancer survival is poor, many patients are open to participating in clinical trials, but the aggressiveness of the disease poses a huge challenge. “It can take a long time to get patients through the current system and into a trial. By that time, it’s often too late, because the patient is no longer well enough.’
On the 8th May 2017, Professor Biankin was awarded a fellowship of the Academy of Medical Sciences, the independent body in the UK representing the diversity of medical science. Fellows are elected for their contribution to biomedical and health research, the generation of new knowledge in medical sciences and its translation into benefits to society.
“Our goal is to give the right treatment, to the right person, at the right time, at the right cost and with the right outcome. Your support of the Beatson Pebble Appeal will ensure we can achieve this vision through the provision of the most advanced facilities and equipment so we can continue to attract the best cancer research scientists in the world.”
Brain Tumour Research Fund
The Brain Tumour Research Fund is extremely important because it helps support smaller research projects that would not necessarily get funding from these larger organisations. These smaller projects often produce very valuable findings. These findings greatly increase the chances of us getting large scale funding to take the projects forward and means a small donation can eventually lead to an important research project that has a real chance of improving outcomes for patients.
The fund has recently been awarded new grants from Cancer Research UK and the Chief Scientist’s Office that will support exciting new laboratory research looking at potential new treatments for glioblastoma, which is the most aggressive form of brain tumour.
Paul O'Gorman Leukaemia Research Centre
The Paul O'Gorman Leukaemia Research Centre is part of the University of Glasgow’s Institute of Cancer Sciences. The Centre was officially opened on the 22nd of May 2008 by Dr Richard Rockefeller. It was built after a fundraising drive by the University of Glasgow in collaboration with Leukaemia & Lymphoma Research (LLR), which saw more than £2.6million raised in six years, through the commitment and generosity of more than 1800 donors and supporters. The facility is state of the art and incorporates the latest research technologies required to perform basic, translational and clinical research. The Centre also benefits from close interactions with the Beatson Institute for Cancer Research and clinical departments of the Beatson West of Scotland Cancer Centre.
The major focus of the Centre is the haemopoietic stem cell which is weakened to cause many different forms of leukaemia. The aim of the Centre aim is to perform basic research to identify novel therapeutic targets for leukaemia and translate our laboratory findings into new effective medicines for patients.
For information on other appeals within the Beatson Pebble Appeal or other University charities, please contact Catherine.McGrory@glasgow.ac.uk or call 0141 330 8007